| Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy FR Schroeck, TL Krupski, L Sun, DM Albala, MM Price, TJ Polascik, ... European urology 54 (4), 785-793, 2008 | 411 | 2008 |
| Use of advanced treatment technologies among men at low risk of dying from prostate cancer BL Jacobs, Y Zhang, FR Schroeck, TA Skolarus, JT Wei, JE Montie, ... Jama 309 (24), 2587-2595, 2013 | 163 | 2013 |
| Regional variation of computed tomographic imaging in the United States and the risk of nephrectomy HG Welch, JS Skinner, FR Schroeck, W Zhou, WC Black JAMA internal medicine 178 (2), 221-227, 2018 | 147 | 2018 |
| Cost of new technologies in prostate cancer treatment: systematic review of costs and cost effectiveness of robotic-assisted laparoscopic prostatectomy, intensity-modulated … FR Schroeck, BL Jacobs, SB Bhayani, PL Nguyen, D Penson, J Hu European urology 72 (5), 712-735, 2017 | 114 | 2017 |
| Trainees do not negatively impact the institutional learning curve for robotic prostatectomy as characterized by operative time, estimated blood loss, and positive surgical … FR Schroeck, CAP de Sousa, RA Kalman, MS Kalia, SA Pierre, ... Urology 71 (4), 597-601, 2008 | 96 | 2008 |
| Harnessing the synergy between improvement science and implementation science in cancer: a call to action B Koczwara, AM Stover, L Davies, MM Davis, L Fleisher, S Ramanadhan, ... Journal of Oncology Practice 14 (6), 335-340, 2018 | 82 | 2018 |
| Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer CP Filson, FR Schroeck, Z Ye, JT Wei, BK Hollenbeck, DC Miller The Journal of urology 192 (1), 75-81, 2014 | 82 | 2014 |
| Comparison of prostate‐specific antigen recurrence‐free survival in a contemporary cohort of patients undergoing either radical retropubic or robot‐assisted laparoscopic … FR Schroeck, L Sun, SJ Freedland, DM Albala, V Mouraviev, TJ Polascik, ... BJU international 102 (1), 28-32, 2008 | 79 | 2008 |
| The burden of cystoscopic bladder cancer surveillance: anxiety, discomfort, and patient preferences for decision making K Koo, L Zubkoff, BE Sirovich, PP Goodney, DJ Robertson, JD Seigne, ... Urology 108, 122-128, 2017 | 75 | 2017 |
| Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy TJ Polascik, JM Mayes, FR Schroeck, L Sun, JF Madden, JW Moul, ... Cancer 115 (10), 2104-2110, 2009 | 74 | 2009 |
| Cyclo19, 31 [D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87) V Magdolen, M Bürgle, N Arroyo de Prada, N Schmiedeberg, C Riemer, ... Biological chemistry, 1197-1205, 2001 | 68 | 2001 |
| Interaction of plasminogen activator inhibitor type‐1 (PAI‐1) with vitronectin: characterization of different PAI‐1 mutants N Arroyo De Prada, F Schroeck, EK Sinner, B Muehlenweg, J Twellmeyer, ... European journal of biochemistry 269 (1), 184-192, 2002 | 64 | 2002 |
| Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn F Schroeck, NA de Prada, S Sperl, M Schmitt, V Magdolen De Gruyter 383 (7-8), 1143-1149, 2002 | 60 | 2002 |
| Understanding hospital readmission intensity after radical cystectomy TA Skolarus, BL Jacobs, FR Schroeck, C He, AM Helfand, J Helm, M Hu, ... The Journal of urology 193 (5), 1500-1506, 2015 | 59 | 2015 |
| Population based trends in the surgical treatment of benign prostatic hyperplasia FR Schroeck, JM Hollingsworth, SR Kaufman, BK Hollenbeck, JT Wei The Journal of urology 188 (5), 1837-1841, 2012 | 59 | 2012 |
| Regional variation in quality of prostate cancer care FR Schroeck, SR Kaufman, BL Jacobs, TA Skolarus, JM Hollingsworth, ... The Journal of urology 191 (4), 957-963, 2014 | 52 | 2014 |
| Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite FR Schroeck, CF Donatucci, EC Smathers, L Sun, DM Albala, TJ Polascik, ... Cancer 113 (10), 2687-2694, 2008 | 51 | 2008 |
| Pretreatment expectations of patients undergoing robotic assisted laparoscopic or open retropubic radical prostatectomy FR Schroeck, TL Krupski, SB Stewart, LL Bañez, L Gerber, DM Albala, ... The Journal of urology 187 (3), 894-898, 2012 | 50 | 2012 |
| Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy FR Schroeck, L Sun, SJ Freedland, J Jayachandran, CN Robertson, ... Prostate cancer and prostatic diseases 11 (4), 371-376, 2008 | 48 | 2008 |
| Improvement science and implementation science in cancer care: identifying areas of synergy and opportunities for further integration DK Check, LL Zullig, MM Davis, L Davies, D Chambers, L Fleisher, ... Journal of general internal medicine 36 (1), 186-195, 2021 | 43 | 2021 |
Philip GoodneySection Chief, Vascular Surgery, Dartmouth Health, and Co-Director, VA Outcomes Group, WRJ VAMCVerified email at hitchcock.org
